Susan Wagland

I joined the department in 2016 as a Clinical Trial Manager for two studies. The PATH-2 study is investigating the effect of platelet-rich plasma (PRP) as a treatment for Achilles tendon ruptures, and the AIM-2 extended follow-up is a 3-year postal follow-up adjunct to AIM, which tested a new casting technique for ankle fractures.

My scientific background is in cell biology and compounds that interfere with cell division in breast cancer. Previously, I was an IT professional, working for blue chip clients as project manager, data analyst and quality manager.